Selpercatinib
Dokument
Fact Sheet
Spezifizierung
Lungenkarzinom, nicht-kleinzellig (NSCLC)
» RET-Alterationen
Stand
Juli 2021
Dies ist die aktuell gültige Version des Dokuments
1Selpercatinib, NSCLC, RET alteration
1 N - number of patients2 RR - remission rate, in %3 PFS - progression-free survival in months5 OS - overall survival in months14 results for control, results for new therapy15 hazard ratio for new therapy17 n. d. not determined; CT - chemotherapy
